Skip to main content

Health condition

Motor neurone disease, a short guide to diagnosis and care.

A quick overview of MND - what it is, how it is diagnosed and how riluzole and multidisciplinary care fit together. For the full guide, see our complete motor neurone disease guide.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against NICE, NHS and the MND Association, with sources listed at the end.

  • 03

    Current for 2026

    Reflects modern UK practice on El Escorial criteria, riluzole, MDT care and non-invasive ventilation.

Key facts

MND at a glance.

The essentials, in plain English - what it is, the subtypes, and how care is organised in the UK today.

  • What it is

    A progressive neurodegenerative disease in which motor neurones in the brain and spinal cord gradually stop working.

  • Main subtypes

    ALS (most common), progressive bulbar palsy, primary lateral sclerosis and progressive muscular atrophy.

  • Core symptom

    Progressive muscle weakness and wasting, often starting in one limb or affecting speech and swallowing.

  • How it is diagnosed

    Clinical assessment plus EMG, nerve conduction studies and MRI to exclude mimicking conditions, using the El Escorial criteria.

  • Drug treatment

    Riluzole is the only licensed disease-modifying drug and can modestly extend survival.

  • Ongoing care

    A multidisciplinary team manages symptoms, alongside non-invasive ventilation and PEG feeding when needed.

Why this guide matters

Early diagnosis, coordinated care.

MND progresses at different rates for different people. The three points below shape everything else on this page.

  • Diagnosis takes time and exclusion

    There is no single test - EMG, MRI and the El Escorial criteria together build the diagnostic picture and rule out mimics.

  • Riluzole is modest but meaningful

    It is the only licensed disease-modifying drug, and starting it early gives the best chance of benefit.

  • The MDT is the backbone of care

    Physiotherapy, speech and language therapy, dietetics and respiratory support work together to manage symptoms as they change.

How the diagnosis is made

From first symptoms to specialist care.

The steps a UK GP or neurologist will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    History and neurological exam

    A GP or neurologist looks for a pattern of painless, progressive weakness, wasting, cramps and twitching (fasciculations).

  2. 02

    Assessing

    Upper and lower motor signs

    Clinicians look for a mix of upper motor neurone signs (stiffness, brisk reflexes) and lower motor neurone signs (wasting, weakness) in the same limb.

  3. 03

    Confirming

    EMG and nerve conduction studies

    Electromyography detects denervation in muscle, while nerve conduction studies help exclude peripheral nerve disease.

  4. 04

    Confirming

    MRI brain and spine

    Used to exclude structural causes such as cervical myelopathy, tumours or multiple sclerosis that can mimic MND.

  5. 05

    Confirming

    Blood tests and, rarely, genetics

    Bloods exclude reversible causes; genetic testing is offered where there is a family history or younger onset.

  6. 06

    Preparing

    El Escorial criteria applied

    Findings are mapped against the El Escorial diagnostic criteria to classify the certainty of an ALS or MND diagnosis.

  7. 07

    Preparing

    Referral to a specialist MND clinic

    Confirmed or suspected diagnoses are referred promptly to a specialist neurology or MND multidisciplinary clinic.

Typical timeline: a first neurology appointment to a confirmed diagnosis usually takes weeks to a few months.

Symptoms

What MND actually looks like.

A gradual mix of weakness, wasting and, in bulbar-onset disease, speech and swallowing change. And the features that mean it’s time to escalate.

  • Limb weakness and wasting

    Progressive weakness, often starting asymmetrically in one hand, arm or leg, with visible muscle wasting.

  • Fasciculations

    Fine, involuntary muscle twitching under the skin, often an early and noticeable sign.

  • Slurred speech (dysarthria)

    Bulbar-onset disease affects the muscles of speech first, causing slurring or a nasal quality.

  • Swallowing difficulty (dysphagia)

    Progressive difficulty swallowing food or liquids, increasing the risk of choking and weight loss.

  • Cramps and stiffness

    Muscle cramps and spasticity are common, particularly as upper motor neurone involvement progresses.

  • Breathing difficulty

    Weakness of the respiratory muscles can cause breathlessness, disturbed sleep and morning headaches.

  • Cognitive and behavioural change

    A minority develop features overlapping with frontotemporal dementia, affecting behaviour or language.

  • Red flag - rapid bulbar decline

    Fast-worsening speech or swallowing problems need urgent specialist and dietetic input to protect nutrition and the airway.

Treatment

How MND is treated in the UK.

Riluzole alongside a coordinated multidisciplinary team, with non-invasive ventilation and PEG feeding introduced as symptoms progress.

  • Riluzole

    The only licensed disease-modifying drug for MND, shown to modestly extend survival, particularly in early disease.

  • Multidisciplinary team care

    Neurology, physiotherapy, occupational therapy, speech and language therapy and dietetics working together to manage symptoms.

  • Non-invasive ventilation (NIV)

    Supports breathing overnight as respiratory muscles weaken, improving quality of life and survival for many patients.

  • PEG feeding

    A percutaneous endoscopic gastrostomy tube maintains nutrition and hydration once swallowing becomes unsafe.

  • Physiotherapy

    Maintains mobility and function for as long as possible and manages spasticity and joint stiffness.

  • Speech and language therapy

    Supports communication strategies and swallowing assessment, including alternative and augmentative communication aids.

  • Symptom-directed medication

    Treats cramps, spasticity, excess saliva and low mood alongside the core disease-modifying and supportive care.

  • Palliative and MND Association support

    Early palliative care input and MND Association services provide practical, emotional and end-of-life support for patients and families.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist charity standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or neurologist knows your history and can tell you which parts apply to you. If in doubt, get seen.

  • NICE. Motor neurone disease: assessment and management (NG42).

  • NHS. Motor neurone disease - overview, symptoms and treatment.

  • MND Association. Living with motor neurone disease - information and support.

  • World Federation of Neurology. El Escorial revisited: diagnostic criteria for ALS.

Red flags

When MND needs urgent attention.

Most day-to-day symptoms are managed by the specialist team. These are the situations that need a faster response.

  • Rapid respiratory decline

    Increasing breathlessness, morning headaches or disturbed sleep suggest respiratory muscle weakness and need urgent respiratory review.

  • Choking or aspiration risk

    Coughing on food or drink, or recurrent chest infections, signal an unsafe swallow needing urgent speech and language therapy input.

  • Sudden severe weight loss

    Rapid, unintentional weight loss may reflect inadequate swallowing or nutrition and should prompt early dietetic and gastrostomy discussion.

  • Falls from leg weakness

    New or worsening falls risk fractures and should trigger a physiotherapy and mobility-aid review.

  • Low mood or suicidal thoughts

    A diagnosis of MND carries a heavy psychological burden - low mood or suicidal thoughts need urgent mental-health support.

  • Carer strain or crisis

    MND places significant demands on family carers - escalating strain deserves prompt social care and MND Association support.

  • Rapid bulbar progression

    Fast-worsening speech and swallowing difficulty warrants urgent specialist MDT reassessment.

  • Uncontrolled secretions

    Excess saliva or thick secretions that are difficult to clear need prompt symptom-control review.

  • Cognitive or behavioural change

    New confusion, personality change or language difficulty should be discussed with the specialist team, as it may reflect frontotemporal involvement.

Living with it

A progressive condition, with dedicated support.

Four things that make the biggest difference day to day - a coordinated team, planning ahead, MND Association support and care for carers too.

A quiet reminder

You are not expected to manage this alone.

A specialist MDT and the MND Association exist specifically to share this load with you and your family.

  1. 01 Team

    Stay connected to the MDT

    Regular contact with your specialist multidisciplinary team helps symptoms and equipment needs stay ahead of the disease.

  2. 02 Plan

    Plan ahead while you can

    Early conversations about future care preferences, including ventilation and feeding, put you in control of decisions later.

  3. 03 Support

    Lean on the MND Association

    Practical equipment, financial advice, and emotional support are available from the moment of diagnosis, not just at the end.

  4. 04 Carers

    Protect carers too

    Respite care and carer support services matter as much as patient care - ask your team what is available locally.

Frequently asked

Everything we get asked about MND.

Quick answers on subtypes, diagnosis, riluzole, ventilation and feeding support.

  • What is motor neurone disease?

    Motor neurone disease (MND) is a progressive neurodegenerative condition in which the nerve cells (motor neurones) controlling voluntary muscles gradually stop working. This leads to progressive muscle weakness and wasting that can affect movement, speech, swallowing and breathing over time.

  • What are the different types of MND?

    The main subtypes are amyotrophic lateral sclerosis (ALS, the most common form), progressive bulbar palsy (affecting speech and swallowing first), primary lateral sclerosis (mainly upper motor neurone features) and progressive muscular atrophy (mainly lower motor neurone features).

  • How is MND diagnosed?

    There is no single test. Diagnosis relies on a careful clinical history and examination, supported by electromyography (EMG) and nerve conduction studies, and an MRI to exclude other conditions such as cervical myelopathy or multiple sclerosis. Findings are assessed against the El Escorial diagnostic criteria.

  • Is there a cure for MND?

    There is currently no cure. Riluzole is the only licensed disease-modifying drug and can modestly slow progression and extend survival, particularly when started early. The main focus of care is a multidisciplinary team managing symptoms and supporting quality of life.

  • What does non-invasive ventilation involve?

    Non-invasive ventilation (NIV) uses a mask, usually worn overnight, to support breathing as the respiratory muscles weaken. It can ease breathlessness, improve sleep quality and has been shown to extend survival and quality of life for many people with MND.

  • Why might someone need a PEG feeding tube?

    A percutaneous endoscopic gastrostomy (PEG) tube is offered once swallowing becomes unsafe or nutrition and hydration can no longer be maintained by mouth. It reduces the risk of choking and aspiration and is usually planned in advance, while the procedure remains lower risk.

Related content

Keep reading.